Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Why Moderna Was a Stock Market Star on Friday
Why Moderna Was a Stock Market Star on Friday
Why Moderna Was a Stock Market Star on Friday
Submitted by
admin
on August 1, 2022 - 10:25am
Source:
Motley Fool
News Tags:
Moderna Therapeutics
vaccines
booster
government contract
Headline:
Why Moderna Was a Stock Market Star on Friday
snippet:
The U.S. government is buying 66 million booster doses, and it has options to purchase as many as 234 million more.
Spikevax continues to be a go-to jab keeping the coronavirus at bay.
Do Not Allow Advertisers to Use My Personal information